Table 2.

Baseline Characteristics of Patients from SCUT with P. aeruginosa Corneal Ulcers: Comparison between Corticosteroid and Placebo Treatment Arms

	Placebo (n = 51)	Corticosteroid (n = 59)	P
Age in years, median (IQR)	41 (30–50)	45 (30–56)	0.39*
Sex, n (%)
Male	34 (67)	35 (59)	0.44†
Female	17 (33)	24 (41)
Duration of symptoms, n (%)
<4 days	27 (53)	28 (47)	0.71†
4–7 days	20 (39)	22 (37)
8–14 days	3 (6)	7 (12)
>14 days	1 (2)	2 (3)
Contact lens use, n (%)	4 (8)	4 (7)	>0.99†
Systemic disease, n (%)‡	4 (8)	2 (3)	0.41†
Ulcer location, n (%)
Entirely in periphery	4 (8)	5 (8)	0.15†
Partially covering 4 mm	35 (69)	30 (51)
Completely fills 4 mm	12 (24)	24 (41)
Visual acuity, logMAR, median (IQR)	1.12 (0.46–1.7)	1.50 (0.46–1.8)	0.10*
Infiltrate/scar size in mm, median (IQR)	3.75 (2.4–5.5)	3.75 (2.7–5.5)	0.29*

^*Rank sum test.

^†Fisher's exact test.

^‡Systemic diseases included diabetes, asthma, Hansen's disease, eczema, psoriasis, HIV, ichthyosis, and malnutrition.